@ -54,4 +54,4 @@ date:: [[2023/12]]
- GHS RDD to consider options for inclusion of key costing data points
- Discuss with GHS economist
- Discuss with KEMRI (e.g. [[Stella Kepha]])
- Can be informed by ongoing work at LSHTM
- Can be informed by ongoing work at [[London School of Hygiene & Tropical Medicine]] for the ALIVE trial (draft anticipated in [[2024/01]])